APA (7th ed.) Citation

O, A., A, B., R, T., S, L., S, P., & B, T. (2026). Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease. Diabetes, metabolic syndrome and obesity : targets and therapy, 19, 577797. https://doi.org/10.2147/DMSO.S577797

Chicago Style (17th ed.) Citation

O, Albai, Braha A, Timar R, Lazar S, Popescu S, and Timar B. "Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease." Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy 19 (2026): 577797. https://doi.org/10.2147/DMSO.S577797.

MLA (9th ed.) Citation

O, Albai, et al. "Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease." Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, vol. 19, 2026, p. 577797, https://doi.org/10.2147/DMSO.S577797.